$MKSI

Mayampurath Ramakumar sold $2.8M of MKSI

Mayampurath Ramakumar (EVP & CFO) sold 8,810 shares of MKS INC (MKSI) at $315.48 ($2.78M total) on 2026-05-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Mayampurath Ramakumar
Published May 26, 2026, 6:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 26, 2026, 6:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MKSI
Neutral
high confidence
Mentioned
$MKSI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MKSINeutralLow
01

Why it matters

Because the sale is explicitly pre-arranged, it is less likely to convey new negative information; trading impact should be limited unless the pattern suggests unusually heavy selling.

02

Market read

A disclosed CFO sale at ~$315.48/share ($2.78M) is unlikely to materially change the market’s view absent additional fundamental news.

03

What to watch

Watch for follow-on filings (additional sales/buys) and whether the post-transaction holding change is part of a larger, recurring 10b5-1 schedule.

Relevance 6/10Timing: Immediate (same-day) but likely short-lived as it is a routine insider transaction disclosure.

Background

The article reports an SEC Form 4 insider transaction: Mayampurath Ramakumar (EVP & CFO) sold MKS Inc shares on 2026-05-22 under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$MKSINeutralHigh confidence
Context

MKS Inc CFO sold 8,810 shares in an open-market transaction ($2.78M) under a pre-arranged 10b5-1 plan, per SEC Form 4.

Expected impact

Low likelihood of sustained price impact; any immediate reaction may fade as 10b5-1 context is recognized.

Evidence & confidence

The filing is a routine Form 4 with explicit 10b5-1 pre-arrangement, and it does not include new fundamentals (earnings, guidance, deals, or litigation).

Market effects

Minimal; this is company-specific insider activity without stated operational or sector-wide catalysts.

None indicated; transaction is a US-listed issuer Form 4.

None indicated; no international deal/regulatory developments mentioned.

Counterpoint

The sale may reflect diversification or scheduled liquidity rather than bearish expectations, especially given the pre-arranged 10b5-1 plan.

Key entities

  • MKS Inc

    Subject of the insider transaction disclosure (EVP & CFO sale under 10b5-1).

  • Mayampurath Ramakumar

    EVP & CFO who executed the open-market sale disclosed in the Form 4.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TTMIHighAI 8/10

TTM Technologies Bets Big on AI, Defense Growth

TTM Technologies (TTMI) announced over $1 billion in investments, including a $650 million acquisition of MKS Inc.'s Ophir Optics unit and a $400 million expansion in China and Malaysia. The company reported strong Q3 earnings but saw a 29% share drop due to debt concerns. TTM's growth is driven by AI and defense demand, with shares up 77% over 12 months.

$MKSIHighAI 9/10

US defence group TTM Technologies to acquire Romanian optics factory as part of USD 650 million deal

TTM Technologies (TTMI) will acquire MKS Inc.'s Ophir Optics for $650M, including facilities in Romania and Israel. The deal, expected to close in Q2 2027, expands TTM's optical solutions for defense and industrial uses. TTM plans to finance the acquisition with cash, future cash flow, and borrowings. MKS aims to reduce debt and focus on core businesses.

$TTMIHighAI 9/10

TTM Technologies, Inc. has entered into a definitive agreement to acquire Ophir Optics business from MKS Inc. for $650 million.

TTM Technologies (TTMI) agreed to acquire Ophir Optics from MKS Inc. (MKSI) for $650M, payable in cash. The deal, expected to close in Q2 2027, is valued at 18x the target's 2026 EBITDA. TTM plans to fund the acquisition through cash, future cash flow, and borrowings. The transaction is expected to be immediately accretive to TTM's EBITDA margin and non-GAAP EPS.